LANZILLI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 1.221
NA - Nord America 803
EU - Europa 374
SA - Sud America 239
AF - Africa 22
OC - Oceania 3
Totale 2.662
Nazione #
US - Stati Uniti d'America 763
SG - Singapore 506
CN - Cina 283
BR - Brasile 190
IT - Italia 177
VN - Vietnam 140
HK - Hong Kong 123
FR - Francia 69
KR - Corea 59
DE - Germania 32
JP - Giappone 29
IN - India 25
NL - Olanda 21
FI - Finlandia 19
MX - Messico 16
AR - Argentina 14
ID - Indonesia 12
RU - Federazione Russa 12
BD - Bangladesh 11
EC - Ecuador 11
CA - Canada 9
GB - Regno Unito 9
MA - Marocco 8
AL - Albania 6
AT - Austria 6
PY - Paraguay 6
ZA - Sudafrica 6
ES - Italia 5
IL - Israele 5
JM - Giamaica 5
UA - Ucraina 5
VE - Venezuela 5
CL - Cile 4
IQ - Iraq 4
PE - Perù 4
PL - Polonia 4
AU - Australia 3
CO - Colombia 3
MY - Malesia 3
SA - Arabia Saudita 3
SE - Svezia 3
UZ - Uzbekistan 3
CR - Costa Rica 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
LT - Lituania 2
NI - Nicaragua 2
PK - Pakistan 2
TH - Thailandia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BW - Botswana 1
ET - Etiopia 1
GF - Guiana Francese 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
LB - Libano 1
MU - Mauritius 1
OM - Oman 1
PR - Porto Rico 1
SV - El Salvador 1
UY - Uruguay 1
Totale 2.662
Città #
Santa Clara 397
Singapore 291
Hong Kong 123
Rome 109
Hefei 92
Seoul 59
Beijing 58
Ho Chi Minh City 55
San Jose 54
Lauterbourg 48
Los Angeles 44
Ashburn 42
Hanoi 34
São Paulo 24
Tokyo 22
Frankfurt am Main 18
Dallas 13
New York 12
Rio de Janeiro 12
Buffalo 11
Helsinki 8
Lappeenranta 8
Chennai 7
Phoenix 7
Brasília 6
Da Nang 6
Düsseldorf 6
Houston 6
Vienna 6
Asunción 5
Biên Hòa 5
San Valentino Torio 5
Bengaluru 4
Curitiba 4
Kingston 4
Minamishinagawa 4
Montreal 4
Naples 4
Quito 4
Amsterdam 3
Bologna 3
Boston 3
Campinas 3
Cape Town 3
Caracas 3
Chicago 3
City of London 3
Guayaquil 3
Itaboraí 3
Jakarta 3
Lima 3
Mexico City 3
Newark 3
Nuremberg 3
Orem 3
Pisa 3
Rabat 3
Tashkent 3
Turku 3
Alexandria 2
Anápolis 2
Aracaju 2
Baghdad 2
Bangkok 2
Belo Horizonte 2
Buenos Aires 2
Can Tho 2
Capim Grosso 2
Casablanca 2
Changsha 2
Charlotte 2
Chongqing 2
Council Bluffs 2
Cà Mau 2
Elk Grove Village 2
Falkenstein 2
Florence 2
Fuzhou 2
Goiânia 2
Guangzhou 2
Hackensack 2
Haiphong 2
Hải Dương 2
Jeddah 2
Johannesburg 2
Juiz de Fora 2
Kyiv 2
Lang Son 2
London 2
Managua 2
Mauá 2
Miami 2
Milwaukee 2
Monroe 2
Mumbai 2
Nairobi 2
Osasco 2
Palermo 2
Paris 2
Philadelphia 2
Totale 1.763
Nome #
Aspirin Inhibits Cancer Stem Cells properties and growth of Glioblastoma multiforme through Rb1 Pathway Modulation 88
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab 86
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment 78
Splenic CD4+ and CD8+ T cells from influenza immune mice concurrently produce in vitro IL2, IL4 and IFNgamma 74
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab 73
Human coronaviruses activate and hijack the host transcription factor HSF1 to enhance viral replication 70
Method for the extraction of pharmaceutically active product from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with immunomodulating activity. 69
Recent perspective on CAR and Fcgamma-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes 63
A possible interplay between HR-HPV and stemness in tumor development: An in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18 infected kb cell-line 63
HLA-DRB1*13:01 allele in the genetic susceptibility to colorectal carcinoma 63
Anti-inflammatory Effect of Resveratrol and Polydatin by In Vitro IL-17 Modulation 59
Anti-inflammatory Effect of Resveratrol and Polydatin by In Vitro IL-17 Modulation. 57
Fc gamma Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance 56
INVITRO COMBINED EFFECTS OF HUMAN INTERFERONS AND INTERLEUKIN-2 ON NATURAL CELL-MEDIATED CYTOTOXICITY 55
Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage 52
In vitro effects of cocaine on cytokine secretion induced in murine splenic CD4+ T cells by antigen-specific stimulation 50
Cell-cycle progression and apoptosis in K562 and Molt-4 cells after cell-to-cell transmission of HTLV-I: modulation by Interferons. 50
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity 47
Reduced susceptibility of NK cells to cancer cells is associated with long term NK cell culture and over-expression of TIMP3 47
The Zinc-Finger AN1-Type Domain 2a Gene Acts as a Regulator of Cell Survival in Human Melanoma: Role of E3-Ligase cIAP2 46
Metodo di estrazione di prodotti ad attività farmaceutica da piante spermatofite, prodotti così ottenuti e loro impiego in medicina, in particolare come sostanze ad attività immunomodulante 45
Polydatin displays antitumor activity against murine melanoma in vitro and in vivo 44
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients 43
DIOXASPIROKETAL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USES THEREOF 43
Antiviral activity of individual versus combined treatments with interferon alpha, beta and gamma on early infection with HTLV-I in vitro. 42
IN VITRO ANTITUMOR ACTIVITY OF OLIVE OIL ANTIOXIDANTS TYROSOL AND HYDROXYTYROSOL AND THEIR METHYL CARBONATE DERIVATIVES 42
Effects of resveratrol on human immune cell function. 42
Attivazione delle risposte immunitarie mediante vaccini batterici 42
Derivati diossaspirochetalici, procedimento di preparazione e usi relativi. 42
In vitro end points for the assessment of cellular immune response-modulating drugs 42
In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. 40
In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. 40
Molecular and Cellular Determinants of Cell-to-Cell Transmission of HCV In Vitro. 39
Metodo di estrazione di prodotti ad attività farmaceutica da piante spermatofite, prodotti così ottenuti e loro impiego in medicina, in particolare come sostanze ad attività antitumorale. 38
Adjuvant therapy of melanoma patients (stage II, III): a pilot immuno-toxicological study 38
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 38
Antitumor activity of Piceid on human colon carcinoma and its effect on adhesion molecules of HUVEC cells 37
Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro. 36
Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. 36
Determination of cytokine co-expression in individual splenic CD4+ and CD8+ T cells from Influenza virus-immune mice 35
Differential effects of short-term or prolonged cocaine exposure on peripheral blood cells in mice. 35
Modification of cell mediated immune-response in patients treated with a polyvalent mechanical bacterial lysate 35
Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact. 35
In vitro combined effects of human Interferons and Interleukin-2 on natural cell-mediated cytotoxicity. 34
Effects of cocaine administration to Influenza Virus-immunized mice on cytokine profiles of individual splenic CD4+ and CD8+ T cells 34
Anti-apoptotic seminal vesicle protein IV inhibits cell-mediated immunity. 34
Dioxaspiroketal Derivatives, Process for Their Preparation and Uses Thereof 33
In vitro and in vivo effects of SCV-07 in a murine B16 melanoma model. 30
EGFR+ GLIOBLASTOMA STEM CELLS TARGETING BY CD16158V-CHIMERIC RECEPTOR T CELLS AND CETUXIMAB 29
Effetto del Trans-resveratrolo (T_RES) sulle risposte immuni MHC e CD1 ristrettte 29
Role of membrane fluidity in Epstein Barr Virus (EBV) infectivity on Akata cell line 28
Method for the extraction of pharmaceutically active product from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with anti-tumoral activity. 27
Early steps in fusion between Epstein Barr Virus (EBV) and a human hepatoma cell line (Li7A) 27
In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. 26
Biological effects of resveratrol on human colo-carcinoma cell lines. 26
Effetto del resveratrolo sui livelli intracellulari di BCG in cellule mononucleate aderenti (AMNC) umane esposte in vitro al micobatterio 26
Effect of synthetic thymic hormones on the cocaine-induced inhibition of the primary immune response in mice. 25
IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5-(3,3' dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitro. 25
METHOD FOR THE EXTRACTION OF PHARMACEUTICALLY ACTIVE PRODUCTS FROM SPERMATOPHYTE PLANTS, PRODUCTS THUS OBTAINED AND THEIR USE IN THE MEDICAL FIELD, IN PARTICULAR AS SUBSTANCES WITH IMMUNOMODULATING ACTIVITY 25
In vitro effects of resveratrol on human cell-mediated immunity. 25
HSP70 production and inhibition of cell proliferation in MOLT-4 T-cells after cell-to-cell transmission of HTLV-I: effect of PGA1. 24
Evidence for Epstein Barr Virus (EBV) fusion with a human hepatoma cell line (Li7A) via a receptor phenotipically distinct from CR2 24
Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells. 24
Bacterial contamination of intravenous catheters and other plastic devices. 19
Totale 2.729
Categoria #
all - tutte 7.893
article - articoli 5.904
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202491 0 0 0 0 0 0 0 0 27 2 25 37
2024/20251.150 25 8 74 38 344 75 13 101 32 38 224 178
2025/20261.488 72 120 162 211 303 98 190 88 81 110 53 0
Totale 2.729